Valuation : BELE LIFEUT

Market Cap 46.6M 40.1M 37.72M 34.46M 64.47M 4.4B 64.64M 446M 173M 2.26B 175M 171M 7.27B P/E 2022 *
-
P/E 2023 210x
Enterprise Value 46.65M 40.14M 37.77M 34.5M 64.54M 4.4B 64.72M 446M 173M 2.26B 175M 171M 7.28B EV / Sales 2022 *
-
EV / Sales 2023 -
Free-Float
-
Yield 2022 *
-
Yield 2023 -

Financials

2022 2023
Net sales - -
Net income -35.39K -30.45K -28.65K -26.17K -48.96K -3.34M -49.09K -339K -131K -1.71M -133K -130K -5.52M 404K 347K 327K 299K 559K 38.12M 560K 3.86M 1.5M 19.56M 1.52M 1.48M 63.01M
Net Debt 1.09M 940K 884K 808K 1.51M 103M 1.52M 10.45M 4.06M 52.92M 4.1M 4.01M 170M 56.58K 48.69K 45.81K 41.85K 78.28K 5.34M 78.49K 541K 210K 2.74M 212K 208K 8.83M
Logo BELE LIFEUT
OSR Holdings, Inc. is a global healthcare company, dedicated to advancing healthcare outcomes and improving the quality of life for people and their families. The Company is focused on building and developing a portfolio of transformative therapies and healthcare solutions. The Company's operating businesses (through its three wholly owned subsidiaries) include developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases and neurovascular intervention medical device and systems distribution in Korea. The Company has business operations in the United States, Europe and South Korea.
Employees
-
Sector
-